全文获取类型
收费全文 | 4576篇 |
免费 | 304篇 |
国内免费 | 117篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 239篇 |
妇产科学 | 179篇 |
基础医学 | 522篇 |
口腔科学 | 131篇 |
临床医学 | 522篇 |
内科学 | 906篇 |
皮肤病学 | 141篇 |
神经病学 | 215篇 |
特种医学 | 303篇 |
外科学 | 644篇 |
综合类 | 132篇 |
预防医学 | 242篇 |
眼科学 | 140篇 |
药学 | 327篇 |
中国医学 | 32篇 |
肿瘤学 | 301篇 |
出版年
2023年 | 32篇 |
2022年 | 24篇 |
2021年 | 131篇 |
2020年 | 74篇 |
2019年 | 87篇 |
2018年 | 104篇 |
2017年 | 91篇 |
2016年 | 83篇 |
2015年 | 97篇 |
2014年 | 149篇 |
2013年 | 160篇 |
2012年 | 252篇 |
2011年 | 279篇 |
2010年 | 174篇 |
2009年 | 171篇 |
2008年 | 182篇 |
2007年 | 253篇 |
2006年 | 199篇 |
2005年 | 209篇 |
2004年 | 166篇 |
2003年 | 141篇 |
2002年 | 151篇 |
2001年 | 168篇 |
2000年 | 144篇 |
1999年 | 117篇 |
1998年 | 74篇 |
1997年 | 75篇 |
1996年 | 68篇 |
1995年 | 70篇 |
1994年 | 57篇 |
1993年 | 47篇 |
1992年 | 71篇 |
1991年 | 53篇 |
1990年 | 63篇 |
1989年 | 70篇 |
1988年 | 68篇 |
1987年 | 72篇 |
1986年 | 67篇 |
1985年 | 43篇 |
1984年 | 29篇 |
1983年 | 29篇 |
1982年 | 24篇 |
1981年 | 24篇 |
1979年 | 22篇 |
1978年 | 17篇 |
1977年 | 21篇 |
1976年 | 22篇 |
1975年 | 14篇 |
1973年 | 16篇 |
1959年 | 13篇 |
排序方式: 共有4997条查询结果,搜索用时 31 毫秒
991.
992.
Yeo W Mo FK Suen JJ Ho WM Chan SL Lau W Koh J Yeung WK Kwan WH Lee KK Mok TS Poon AN Lam KC Hui EK Zee B 《Breast cancer research and treatment》2009,113(3):529-535
Objectives This is a single center, randomized, double-blind placebo-controlled study to evaluate the NK(1)-receptor antagonist, aprepitant,
in Chinese breast cancer patients. The primary objective was to compare the efficacy of aprepitant-based antiemetic regimen
and standard antiemetic regimen for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients who received
moderately emetogenic chemotherapy. The secondary objective was to compare the patient-reported quality of life in these two
groups of patients. Patients and Methods Eligible breast cancer patients were chemotherapy-naive and treated with adjuvant AC chemotherapy (i.e. doxorubicin 60 mg/m2 and cyclophosphamide 600 mg/m2). Patients were randomly assigned to either an aprepitant-based regimen (day 1, aprepitant 125 mg, ondansetron 8 mg, and
dexamethasone 12 mg before chemotherapy and ondansetron 8 mg 8 h later; days 2 through 3, aprepitant 80 qd) or a control arm
which consisted of standard regimen (day 1, ondansetron 8 mg and dexamethasone 20 mg before chemotherapy and ondansetron 8 mg
8 h later; days 2 through 3, ondansetron 8 mg bid). Data on nausea, vomiting, and use of rescue medication were collected
with a self-report diary, patients quality of life were assessed by self-administered Functional Living Index-Emesis (FLIE).
Results Of 127 patients randomized, 124 were assessable. For CINV in Cycle 1 AC, there was no significant difference in the proportion
of patients with reported complete response, complete protection, total control, ‘no vomiting’, ‘no significant nausea’ and
‘no nausea’. The requirement of rescue medication appears to be lesser in patients treated with the aprepitant-based regimen
compared to those with the standard regimen (11% vs. 20%; P = 0.06). Assessment of FLIE revealed that while there was no difference in the nausea domain and the total score between
the two groups; however, patients receiving standard antiemetic regimen had significantly worse quality of life in the vomiting
domain (mean score [SD] = 23.99 [30.79]) when compared with those who received the aprepitant-based regimen (mean score [SD] = 3.40
[13.18]) (P = 0.0002). Both treatments were generally well tolerated. Patients treated with the aprepitant-based regimen had a significantly
lower incidence of neutropenia (53.2% vs. 35.5%, P = 0.0468), grade ≥ 3 neutropenia (21.0% vs. 45.2, P = 0.0042) and delay in subsequent cycle of chemotherapy (8.1% vs. 27.4%, P = 0.0048). Conclusion The aprepitant regimen appears to reduce the requirement of rescue medication when compared with the control regimen for
prevention of CINV in patients receiving both an anthracycline and cyclophosphamide, and is associated with a better quality
of life during adjuvant AC chemotherapy. 相似文献
993.
Vivian Wai Yan Lui Elaine Yue Ling Wong Yeung Ho Bo Hong Sze Chuen Cesar Wong Qian Tao Gigi Ching Gee Choi Thomas Chi Chuen Au Kakiu Ho Daisy Mei Sze Yau Brigette Buig Yue Ma Edwin Pun Hui Andrew Sai‐Kit Chan Chi‐Man Tsang Sai‐Wah Tsao Jennifer Rubin Grandis Anthony Tak‐Cheung Chan 《International journal of cancer. Journal international du cancer》2009,125(8):1884-1893
Nasopharyngeal cancer (NPC) is an Epstein‐Barr virus (EBV)‐associated head and neck cancer prevalent in Asia. Although with reasons not fully understood, the intrinsic invasiveness of NPC is believed to be EBV‐linked. Recently, EBV was found to induce STAT3 activation. Constitutive STAT3 activation correlated with advanced clinical staging in NPC. We hypothesized that STAT3 activation by EBV directly contributes to the intrinsic invasiveness of NPC cells. Phospho‐STAT3‐Tyr705 was detected in high percentage of NPC tumors (7/10 cases). Using a paired NPC cell line model, HONE‐1 and the EBV‐infected counterpart, HONE‐1‐EBV, we found that HONE‐1‐EBV expressed a higher level of phospho‐STAT3‐Tyr705 and was ~11‐fold more invasive than HONE‐1. In HONE‐1‐EBV, STAT3 siRNA targeting inhibited both spontaneous and serum‐induced invasion, as well as cell growth. Conversely, activation of STAT3 (by expressing an activated STAT3 mutant, namely STAT3C) in the parental HONE‐1, mimicking EBV‐induced STAT3 activation, significantly enhanced its invasiveness and proliferation, which was accompanied by increased expression of markers of mesenchymal status, proliferation and anti‐apoptosis. Our results demonstrated that EBV‐induced STAT3 activation is responsible for NPC cell proliferation and invasion. This was further confirmed by a small molecule inhibitor of JAK/STAT3, JSI‐124. JSI‐124 inhibited STAT3 activation in HONE‐1‐EBV, with subsequent growth inhibition, induction of PARP cleavage, abrogation of anchorage‐independent growth and invasion. We found that EBV‐independent activation of STAT3 by a growth factor, EGF, also contributed to NPC invasion. In conclusion, EBV‐induced STAT3 activation directly contributes to the intrinsic invasiveness of NPC cells and STAT3 targeting may be beneficial in treating aggressive NPC. © 2009 UICC 相似文献
994.
The lack of a proper animal model has impeded understanding of the molecular mechanism of leukemia associated with the MLL-AF4 fusion. In this issue of Cancer Cell, Krivtsov et al. report a much-improved murine Mll-AF4 model and propose a molecular link with H3K79 methylation mediated by the histone methyltransferase DOT1L. 相似文献
995.
Woods Ignatoski KM Grewal NK Markwart SM Vellaichamy A Chinnaiyan AM Yeung K Ray ME Keller ET 《International journal of radiation oncology, biology, physics》2008,72(1):153-160
PURPOSE: External beam radiotherapy (RT) is often used in an attempt to cure localized prostate cancer (PCa), but it is only palliative against disseminated disease. Raf kinase inhibitory protein (RKIP) is a metastasis suppressor whose expression is reduced in approximately 50% of localized PCa tissues and is absent in metastases. Chemotherapeutic agents have been shown to induce tumor apoptosis through induction of RKIP expression. Our goal was to test whether RT similarly induces apoptosis through induction of RKIP expression. METHODS AND MATERIALS: The C4-2B PCa cell line was engineered to overexpress or underexpress RKIP. The engineered cells were tested for apoptosis in cell culture and tumor regression in mice after RT. RESULTS: RT induced both RKIP expression and apoptosis of PCa cells. Overexpression of RKIP sensitized PCa cells to radiation-induced apoptosis. In contrast, short-hairpin targeting of RKIP, so that RT could not induce RKIP expression, protected cells from radiation-induced apoptosis. In a murine model, knockdown of RKIP in PCa cells diminished radiation-induced apoptosis. Molecular concept mapping of genes altered on manipulation of RKIP expression revealed an inverse correlation with the concept of genes altered by RT. CONCLUSION: The data presented in this report indicate that the loss of RKIP, as seen in primary PCa tumors and metastases, confers protection against radiation-induced apoptosis. Therefore, it is conceivable that the loss of RKIP confers a growth advantage on PCa cells at distant sites, because the loss of RKIP would decrease apoptosis, favoring proliferation. 相似文献
996.
997.
Yeung BH Wong KY Lin MC Wong CK Mashima T Tsuruo T Wong AS 《British journal of cancer》2008,99(2):283-293
Chemoresistance and therapeutic selectivity are major obstacles to successful chemotherapy of ovarian cancer. Manganese superoxide disumutase (MnSOD) is an important antioxidant enzyme responsible for the elimination of superoxide radicals. We reported here that MnSOD was significantly elevated in ovarian cancer cells and its overexpression was one of the mechanisms that increased resistance to apoptosis in cancer cells. Knockdown of MnSOD by small-interfering RNA (siRNA) led to an increase in superoxide generation and sensitisation of ovarian cancer cells to the two front-line anti-cancer agents doxorubicin and paclitaxel whose action involved free-radical generation. This synergistic effect was not observed in non-transformed ovarian surface epithelial cells. Furthermore, our results revealed that this combination at the cellular level augmented activation of caspase-3 and caspase-9, but not caspase-8, suggesting involvement of an intrinsic apoptotic pathway. Evaluation of signalling pathways showed that MnSOD siRNA enhanced doxorubicin- and paclitaxel-induced phosphorylation of extracellular signal-regulated kinase 1/2. Akt activation was not affected. These results identify a novel chemoresistance mechanism in ovarian cancer, and show that combination of drugs capable of suppressing MnSOD with conventional chemotherapeutic agents may provide a novel strategy with a superior therapeutic index and advantage for the treatment of refractory ovarian cancer. 相似文献
998.
Yeung ML Yasunaga J Bennasser Y Dusetti N Harris D Ahmad N Matsuoka M Jeang KT 《Cancer research》2008,68(21):8976-8985
A role for microRNAs (miRNA) in human T-cell leukemia virus 1 (HTLV-1)-mediated cellular transformation has not been described. Here, we profiled miRNA expression in HTLV-1-transformed human T-cell lines and primary peripheral blood mononuclear cells from adult T-cell leukemia patients. Analyses of 11 different profiles revealed six miRNAs that were consistently up-regulated. Two of the up-regulated miRNAs (miR-93 and miR-130b) target the 3' untranslated region (3'UTR) of the mRNA for a tumor suppressor protein, tumor protein 53-induced nuclear protein 1 (TP53INP1). A low expression level of TP53INP1 protein was found in HTLV-1-transformed cells. Additionally, when antagomirs were used to knock down miR-93 and miR-130b in these cells, the expression of TP53INP1 was increased, suggesting that the latter is regulated inside cells by the former. A role for TP53INP1 in regulating cell growth was established by experiments that showed that enhanced TP53INP1 expression increased apoptosis. Collectively, the findings implicate a miR-93/miR-130b-TP53INP1 axis that affects the proliferation and survival of HTLV-1-infected/transformed cells. 相似文献
999.
Numerous vitamin supplements are available over-the-counter to the general public. Some such supplements are available as candy-like chewable preparations to encourage consumption by children. We report 3 cases of overdose of such preparations. Each patient had taken an estimated 200,000 to 300,000 IU of vitamin A. Their circulating vitamin A (retinol and retinyl palmitate) concentrations were monitored over a 6-month period. There were no clinical or biochemical complications noted. However, there were marked increases in both retinol and retinyl palmitate concentrations above age-related reference ranges. In particular, it took 1 to 3 weeks for the serum retinol concentrations to peak and many months for them to normalize. Parents should be warned about the dangers of excessive vitamin consumption. Clinicians should be aware of the late peak in serum retinol concentrations, which may lead to late complications of vitamin A overdose. 相似文献
1000.
Kim Hung Lee Y. H. Tam C. K. Yeung K. W. Chan J. D. Y. Sihoe S. T. Cheung J. W. C. Mou 《Pediatric surgery international》2009,25(4):355-360
Purpose To assess the intermediate-term result of the use of the minimally invasive technique in the treatment of choledochal cysts
in children.
Methods This is a retrospective review of all cases of choledochal cyst treated in the tertiary referral centre. The surgical technique
is described and all the medical records were reviewed to assess the intraoperative and postoperative complications and follow-up
problems.
Results From October 2000 to April 2008, laparoscopic excision and reconstruction were attempted in 37 patients. Laparoscopic surgery
was successfully performed in 34. Conversion was required in three patients due to oozing on cyst dissection (two) and bleeding
from small bowel mesentry (one) during the early part of the series. Postoperative complications were observed in 15 patients
including subhepatic collection (6), bile leakage (3), minor wound infection (4) and prolonged ileus (2). At a mean follow-up
of 4.2 years, four patients developed surgical complications including intrahepatic ductal strictures in a type IV cyst (one),
stump pancreatitis (one), terminal ileal obstruction from internal herniation (one) and cholangitis (one). The cosmetic result
was good in all patients.
Conclusion We conclude that laparoscopic excision and reconstruction can be safely performed in children with a choledochal cyst with
satisfactory intermediate-term results. 相似文献